Parkinson’s Disease: Available Clinical and Promising Omics Tests for Diagnostics, Disease Risk Assessment, and Pharmacotherapy Personalization
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Parkinson’s Disease: Available Clinical and Promising Omics Tests for Diagnostics, Disease Risk Assessment, and Pharmacotherapy Personalization
Authors
Keywords
-
Journal
Diagnostics
Volume 10, Issue 5, Pages 339
Publisher
MDPI AG
Online
2020-05-25
DOI
10.3390/diagnostics10050339
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mass Spectrometry-Based Metabolomics Analysis of Obese Patients’ Blood Plasma
- (2020) Petr G. Lokhov et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Diagnosis and Treatment of Parkinson Disease
- (2020) Melissa J. Armstrong et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Combined Visualization of Nigrosome-1 and Neuromelanin in the Substantia Nigra Using 3T MRI for the Differential Diagnosis of Essential Tremor and de novo Parkinson's Disease
- (2019) Lirong Jin et al. Frontiers in Neurology
- Different Circulating Trace Amine Profiles in De Novo and Treated Parkinson’s Disease Patients
- (2019) Giovanni D’Andrea et al. Scientific Reports
- How I do it: The Neuro-Ophthalmological Assessment in Parkinson’s Disease
- (2019) Carlijn D.J.M. Borm et al. Journal of Parkinsons Disease
- Hyposmia as a Predictive Marker of Parkinson’s Disease: A Systematic Review and Meta-Analysis
- (2019) Xin Sui et al. Biomed Research International
- Glucocerebrosidase and its relevance to Parkinson disease
- (2019) Jenny Do et al. Molecular Neurodegeneration
- Update of the MDS research criteria for prodromal Parkinson's disease
- (2019) Sebastian Heinzel et al. MOVEMENT DISORDERS
- Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
- (2019) Mike A Nalls et al. LANCET NEUROLOGY
- Identification of distinct blood-based biomarkers in early stage of Parkinson’s disease
- (2019) Yingyan Wu et al. NEUROLOGICAL SCIENCES
- The Challenge and Opportunity to Diagnose Parkinson's Disease in Midlife
- (2019) Alexander Kilzheimer et al. Frontiers in Neurology
- Severe hyposmia and aberrant functional connectivity in cognitively normal Parkinson’s disease
- (2018) Noritaka Yoneyama et al. PLoS One
- Whole-Exome Sequencing in Searching for New Variants Associated With the Development of Parkinson’s Disease
- (2018) Marina V. Shulskaya et al. Frontiers in Aging Neuroscience
- Evaluation of RNA Blood Biomarkers in the Parkinson’s Disease Biomarkers Program
- (2018) Jose A. Santiago et al. Frontiers in Aging Neuroscience
- Meta-Analysis of Visual Evoked Potential and Parkinson’s Disease
- (2018) Song-bin He et al. Parkinsons Disease
- Validation of the MDS clinical diagnostic criteria for Parkinson's disease
- (2018) Ronald B. Postuma et al. MOVEMENT DISORDERS
- Parkinson Disease
- (2018) Stephen G. Reich et al. MEDICAL CLINICS OF NORTH AMERICA
- The biomarker potential of cell-free microRNA from cerebrospinal fluid in Parkinsonian Syndromes
- (2018) Charlotte Starhof et al. MOVEMENT DISORDERS
- Life span pigmentation changes of the substantia nigra detected by neuromelanin-sensitive MRI
- (2018) Yue Xing et al. MOVEMENT DISORDERS
- The role of monogenic genes in idiopathic Parkinson’s disease
- (2018) Xylena Reed et al. NEUROBIOLOGY OF DISEASE
- Atypical parkinsonian syndromes: a general neurologist's perspective
- (2017) A. B. Deutschländer et al. EUROPEAN JOURNAL OF NEUROLOGY
- The measuring of substantia nigra hyperechogenicity in an Italian cohort of Parkinson disease patients: a case/control study (NOBIS Study)
- (2017) Patrizio Prati et al. JOURNAL OF NEURAL TRANSMISSION
- Epidemiology of Parkinson’s disease
- (2017) Ole-Bjørn Tysnes et al. JOURNAL OF NEURAL TRANSMISSION
- Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort
- (2017) Seyed-Mohammad Fereshtehnejad et al. MOVEMENT DISORDERS
- Ocular and visual disorders in Parkinson's disease: Common but frequently overlooked
- (2017) Merel S. Ekker et al. PARKINSONISM & RELATED DISORDERS
- Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis
- (2017) Azin Shafieesabet et al. PARKINSONISM & RELATED DISORDERS
- Protocol of a single group prospective observational study on the diagnostic value of 3T susceptibility weighted MRI of nigrosome-1 in patients with parkinsonian symptoms: the N3iPD study (nigrosomalironimagingin Parkinson’s disease)
- (2017) Stefan T Schwarz et al. BMJ Open
- Technologies Assessing Limb Bradykinesia in Parkinson’s Disease
- (2017) Hasan Hasan et al. Journal of Parkinsons Disease
- Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts
- (2017) Usman Saeed et al. Translational Neurodegeneration
- Exploration of individuality in drug metabolism by high-throughput metabolomics: The fast line for personalized medicine
- (2016) Oxana Trifonova et al. DRUG DISCOVERY TODAY
- Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map-weighted imaging (SMWI)
- (2016) Yoonho Nam et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- The clinical symptoms of Parkinson's disease
- (2016) Sigurlaug Sveinbjornsdottir JOURNAL OF NEUROCHEMISTRY
- Substantia Nigra Hyperechogenicity
- (2016) Toomas Toomsoo et al. JOURNAL OF ULTRASOUND IN MEDICINE
- Genetics of Parkinson's disease
- (2016) Christina M. Lill MOLECULAR AND CELLULAR PROBES
- Advances in markers of prodromal Parkinson disease
- (2016) Ronald B. Postuma et al. Nature Reviews Neurology
- Relation of 18-F-Dopa PET with hypokinesia-rigidity, tremor and freezing in Parkinson’s disease
- (2016) Angelina R.A. Pikstra et al. NeuroImage-Clinical
- Nigrosome 1 Detection at 3T MRI for the Diagnosis of Early-Stage Idiopathic Parkinson Disease: Assessment of Diagnostic Accuracy and Agreement on Imaging Asymmetry and Clinical Laterality
- (2015) Y. Noh et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients
- (2015) Christine R. Swanson et al. MOVEMENT DISORDERS
- Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism
- (2015) Eva Reiter et al. MOVEMENT DISORDERS
- MDS clinical diagnostic criteria for Parkinson's disease
- (2015) Ronald B. Postuma et al. MOVEMENT DISORDERS
- MDS research criteria for prodromal Parkinson's disease
- (2015) Daniela Berg et al. MOVEMENT DISORDERS
- Differential effects of severe vs mild GBA mutations on Parkinson disease
- (2015) Z. Gan-Or et al. NEUROLOGY
- Oculo-visual changes and clinical considerations affecting older patients with dementia
- (2015) Richard Armstrong et al. OPHTHALMIC AND PHYSIOLOGICAL OPTICS
- Technologies for Assessment of Motor Disorders in Parkinson’s Disease: A Review
- (2015) Qi Oung et al. SENSORS
- Potential Biomarkers of the Earliest Clinical Stages of Parkinson’s Disease
- (2015) Anelya Kh. Alieva et al. Parkinsons Disease
- Applications of visual evoked potentials and Fourier-domain optical coherence tomography in Parkinson’s disease: a controlled study
- (2014) Lucas Barasnevicius Quagliato et al. ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
- 7 tesla magnetic resonance imaging: A closer look at substantia nigra anatomy in Parkinson's disease
- (2014) Stéphane Lehéricy et al. MOVEMENT DISORDERS
- Neuroimaging in Parkinson disease: from research setting to clinical practice
- (2014) Marios Politis Nature Reviews Neurology
- Diagnosing Impaired Glucose Tolerance Using Direct Infusion Mass Spectrometry of Blood Plasma
- (2014) Petr G. Lokhov et al. PLoS One
- MR Imaging of the Substantia Nigra at 7 T Enables Diagnosis of Parkinson Disease
- (2014) Mirco Cosottini et al. RADIOLOGY
- Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease
- (2013) M. T. Pellecchia et al. EUROPEAN JOURNAL OF NEUROLOGY
- Mutations in GBA and risk of Parkinson’s disease: a meta-analysis based on 25 case-control studies
- (2013) Xueye Mao et al. NEUROLOGICAL RESEARCH
- Detection of copy number changes in genes associated with Parkinson's disease in Iranian patients
- (2013) Hossein Darvish et al. NEUROSCIENCE LETTERS
- Postgenomics Diagnostics: Metabolomics Approaches to Human Blood Profiling
- (2013) Oxana Trifonova et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Hyposmia: a possible biomarker of Parkinson’s disease
- (2013) Qian Xiao et al. Neuroscience Bulletin
- Genetics of Parkinson's Disease
- (2013) C. Klein et al. Cold Spring Harbor Perspectives in Medicine
- Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease
- (2013) Ju-Hee Kang JAMA Neurology
- Cerebrospinal Fluid Biomarker Candidates for Parkinsonian Disorders
- (2013) Radu Constantinescu et al. Frontiers in Neurology
- Meta-analysis of early nonmotor features and risk factors for Parkinson disease
- (2012) Alastair J. Noyce et al. ANNALS OF NEUROLOGY
- Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson’s disease and other synucleinopathies
- (2012) David S. Goldstein et al. BRAIN
- Biomarkers of Parkinson's disease: current status and future perspectives
- (2012) Jian Wang et al. DRUG DISCOVERY TODAY
- Blood plasma metabolites and the risk of developing lung cancer in Russia
- (2012) Petr G. Lokhov et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease
- (2012) A. Berardelli et al. EUROPEAN JOURNAL OF NEUROLOGY
- The PRIPS study: screening battery for subjects at risk for Parkinson's disease
- (2012) D. Berg et al. EUROPEAN JOURNAL OF NEUROLOGY
- Long-term course of substantia nigra hyperechogenicity in Parkinson's disease
- (2012) Stefanie Behnke et al. MOVEMENT DISORDERS
- Defining at-risk populations for Parkinson's disease: Lessons from ongoing studies
- (2012) Daniela Berg et al. MOVEMENT DISORDERS
- Diagnosis of Parkinson's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera
- (2012) Min Han et al. PLoS One
- Phosphorylated -Synuclein in Parkinson's Disease
- (2012) Y. Wang et al. Science Translational Medicine
- DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease
- (2012) Xiangmin Lin et al. Scientific Reports
- Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease
- (2011) Penelope G. Foulds et al. FASEB JOURNAL
- Diagnosis of lung cancer based on direct-infusion electrospray mass spectrometry of blood plasma metabolites
- (2011) Petr G. Lokhov et al. INTERNATIONAL JOURNAL OF MASS SPECTROMETRY
- A critical appraisal of the premotor symptoms of Parkinson's disease: Potential usefulness in early diagnosis and design of neuroprotective trials
- (2011) Anthony E. Lang MOVEMENT DISORDERS
- Parkinson's disease: Diagnosis
- (2011) David J. Brooks PARKINSONISM & RELATED DISORDERS
- Direct infusion mass spectrometry or liquid chromatography mass spectrometry for human metabonomics? A serum metabonomic study of kidney cancer
- (2010) Lin Lin et al. ANALYST
- Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
- (2010) Min Shi et al. ANNALS OF NEUROLOGY
- Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease
- (2010) Min Shi et al. NEUROSCIENCE LETTERS
- Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease
- (2009) Alberto Ascherio ARCHIVES OF NEUROLOGY
- Metabolite profiling of blood plasma of patients with prostate cancer
- (2009) Petr G. Lokhov et al. Metabolomics
- Analysis of exon dosage using MLPA in South African Parkinson's disease patients
- (2009) Rowena J. Keyser et al. NEUROGENETICS
- How Can Neuroimaging Help in the Diagnosis of Movement Disorders?
- (2009) Helen Ling et al. NEUROIMAGING CLINICS OF NORTH AMERICA
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
- (2009) E. Sidransky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metabolomic profiling to develop blood biomarkers for Parkinson's disease
- (2008) M. Bogdanov et al. BRAIN
- Transcranial sonography in movement disorders
- (2008) Daniela Berg et al. LANCET NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now